![Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41409-022-01748-w/MediaObjects/41409_2022_1748_Fig1_HTML.png)
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood
![The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed - Bakunina - 2022 - Cancer Medicine - Wiley Online Library The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed - Bakunina - 2022 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/96b0b516-af4d-4dd1-80c7-9e0f93100437/cam44392-fig-0005-m.jpg)
The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed - Bakunina - 2022 - Cancer Medicine - Wiley Online Library
![Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials | Leukemia Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-018-0274-y/MediaObjects/41375_2018_274_Fig1_HTML.png)
Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials | Leukemia
![Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka](https://cyberleninka.org/viewer_images/1086573/f/1.png)
Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka
![Cancers | Free Full-Text | Real-World Experience of Measurable Residual Disease Response and Prognosis in Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine Cancers | Free Full-Text | Real-World Experience of Measurable Residual Disease Response and Prognosis in Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine](https://pub.mdpi-res.com/cancers/cancers-14-03576/article_deploy/html/images/cancers-14-03576-g002.png?1658825848)
Cancers | Free Full-Text | Real-World Experience of Measurable Residual Disease Response and Prognosis in Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine
![Acute myeloid leukemia: 2019 update on risk‐stratification and management - Estey - 2018 - American Journal of Hematology - Wiley Online Library Acute myeloid leukemia: 2019 update on risk‐stratification and management - Estey - 2018 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5877b5ad-60ad-45eb-8eb7-a0f3f4165ee8/ajh25214-fig-0005-m.jpg)
Acute myeloid leukemia: 2019 update on risk‐stratification and management - Estey - 2018 - American Journal of Hematology - Wiley Online Library
![A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia | Leukemia A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-019-0604-8/MediaObjects/41375_2019_604_Fig1_HTML.png)